Strengthening and opening up health research by sharing our raw data

Circulation: Cardiovascular Quality and Outcomes

Volumn 5, Issue 2, 2012, Pages 236-237

  Gøtzsche, Peter C ^a  

^a Nordic Cochrane Centre   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; ROFECOXIB;

CLINICAL RESEARCH; HEALTH; HEART INFARCTION; HUMAN; INFORMATION PROCESSING; LONGEVITY; NOTE; PRIORITY JOURNAL; PUBLICATION;

BIOMEDICAL RESEARCH; COOPERATIVE BEHAVIOR; HUMANS; INFORMATION DISSEMINATION;

EID: 84860870588     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.112.965277     Document Type: Note

References (11)

1. Gøtzsche PC. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials. 2011;12:249. http://www.trialsjournal. com/content/12/1/249/.
2. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan AW, Cronin E, Decullier E, Easterbrook PJ, Von Elm E, Gamble C, Ghersi D, Ioannidis JP, Simes J, Williamson PR. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008; 3:e3081.
3. Lenzer J. FDA is incapable of protecting US "against another Vioxx." BMJ. 2004;329:1253.
4. Topol EJ. Failing the public health: Rofecoxib, Merck, and the FDA. N Engl J Med. 2004;351:1707-1709. (Pubitemid 39383201)
5. Cohen D. Complications: Tracking down the data on oseltamivir. BMJ. 2009;339:b5387.
6. Jefferson T, Doshi P, Heneghan C. Ensuring safe and effective drugs: Who can do what it takes? BMJ. 2011;342:c7258.
7. Cohen D. Search for evidence goes on. BMJ. 2012;344:e458.
8. Jefferson T, Jones MA, Doshi P, Del Mar CB, Heneghan CJ, Hama R, Thompson MJ. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012;1:CD008965.
9. House of Commons Health Committee. The influence of the pharmaceutical industry: Fourth Report of Session 2004- 05. http://www. publications. parliament.uk/pa/cm200405/cmselect/cmhealth/42/42.pdf. Accessed April 26, 2005.
10. Gøtzsche PC, Jørgensen AW. Opening up data at the European Medicines Agency. BMJ. 2011;342:d2686.
11. Gøtzsche PC, Johansen HK. Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst Rev. 2010;7:CD007851.